These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20173156)

  • 21. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
    Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
    Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C; Schubiger PA; Schibli R
    Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
    Müller C; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
    Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
    Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.
    Joosten L; Brom M; Schäfer MKH; Boerman OC; Weihe E; Gotthardt M
    Sci Rep; 2017 May; 7(1):1751. PubMed ID: 28496188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
    Ke CY; Mathias CJ; Green MA
    J Am Chem Soc; 2005 May; 127(20):7421-6. PubMed ID: 15898791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats.
    Higuchi T; Yang DJ; Ilgan S; Tansey LW; Zareneyrizi F; Inoue T; Endo K; Kim EE; Podoloff DA
    Anticancer Drugs; 1999 Jan; 10(1):89-95. PubMed ID: 10194551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical characterisation of 111In-DTPA-trastuzumab.
    Lub-de Hooge MN; Kosterink JG; Perik PJ; Nijnuis H; Tran L; Bart J; Suurmeijer AJ; de Jong S; Jager PL; de Vries EG
    Br J Pharmacol; 2004 Sep; 143(1):99-106. PubMed ID: 15289297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
    Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
    J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
    Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Sabbah EN; Kadouche J; Ellison D; Finucane C; Decaudin D; Mather SJ
    Nucl Med Biol; 2007 Apr; 34(3):293-304. PubMed ID: 17383579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
    Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C
    J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
    Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
    J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
    Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
    Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
    Shan X; Yuan D; Xiong F; Gu N; Wang P
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, biodistribution, and small animal PET of 45Ti-transferrin.
    Vavere AL; Welch MJ
    J Nucl Med; 2005 Apr; 46(4):683-90. PubMed ID: 15809492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
    Hanaoka H; Mukai T; Tamamura H; Mori T; Ishino S; Ogawa K; Iida Y; Doi R; Fujii N; Saji H
    Nucl Med Biol; 2006 May; 33(4):489-94. PubMed ID: 16720240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
    Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
    Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.